Literature DB >> 11390629

Variant chromatin structure of the oriP region of Epstein-Barr virus and regulation of EBER1 expression by upstream sequences and oriP.

B Wensing1, A Stühler, P Jenkins, M Hollyoake, C E Karstegl, P J Farrell.   

Abstract

Most of the Epstein-Barr virus genome in latently infected cells is in a standard nucleosomal structure, but the region encompassing oriP and the Epstein-Barr virus-encoded small RNA (EBER) genes shows a distinctive pattern when digested with micrococcal nuclease. This pattern corresponds to a previously mapped nuclear matrix attachment region. Although the EBER genes are adjacent to oriP, there is only a two- to fourfold effect of oriP on EBER expression. However, sequences containing a consensus ATF site upstream of EBER1 are important for EBER1 expression.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11390629      PMCID： PMC114343          DOI： 10.1128/JVI.75.13.6235-6241.2001

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  22 in total

1.  Definition of the transcription factors which bind the differentiation responsive element of the Epstein-Barr virus BZLF1 Z promoter in human epithelial cells.

Authors:  P MacCallum; L Karimi; L J Nicholson
Journal:  J Gen Virol       Date:  1999-06       Impact factor: 3.891

2.  A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection.

Authors:  B Sugden; N Warren
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

3.  Chromatin structure of Epstein-Barr virus.

Authors:  P J Dyson; P J Farrell
Journal:  J Gen Virol       Date:  1985-09       Impact factor: 3.891

4.  Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines.

Authors:  J E Shaw; L F Levinger; C W Carter
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

5.  Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.

Authors:  A L Adamson; D Darr; E Holley-Guthrie; R A Johnson; A Mauser; J Swenson; S Kenney
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers.

Authors:  T W Hai; F Liu; W J Coukos; M R Green
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

7.  DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

Authors:  R Baer; A T Bankier; M D Biggin; P L Deininger; P J Farrell; T J Gibson; G Hatfull; G S Hudson; S C Satchwell; C Séguin
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

8.  Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata.

Authors:  J Komano; S Maruo; K Kurozumi; T Oda; K Takada
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

9.  Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia.

Authors:  K Gilligan; P Rajadurai; L Resnick; N Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

10.  Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements.

Authors:  J G Howe; M D Shu
Journal:  Cell       Date:  1989-06-02       Impact factor: 41.582
View more
  10 in total

1.  The CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation.

Authors:  Zhong Deng; Chi-Ju Chen; Michaela Chamberlin; Fang Lu; Gerd A Blobel; David Speicher; Lisa Ann Cirillo; Kenneth S Zaret; Paul M Lieberman
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

2.  Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus.

Authors:  Charles M Chau; Paul M Lieberman
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Chromatin profiling of Epstein-Barr virus latency control region.

Authors:  Latasha Day; Charles M Chau; Michael Nebozhyn; Andrew J Rennekamp; Michael Showe; Paul M Lieberman
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

4.  Sequences adjacent to oriP improve the persistence of Epstein-Barr virus-based episomes in B cells.

Authors:  R E White; R Wade-Martins; M R James
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 5.  Epigenetic regulation of EBV persistence and oncogenesis.

Authors:  Italo Tempera; Paul M Lieberman
Journal:  Semin Cancer Biol       Date:  2014-01-24       Impact factor: 15.707

6.  Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.

Authors:  Thomas J Owen; John D O'Neil; Christopher W Dawson; Chunfang Hu; Xiaoyi Chen; Yunhong Yao; Victoria H J Wood; Louise E Mitchell; Robert J White; Lawrence S Young; John R Arrand
Journal:  Mol Cancer       Date:  2010-09-15       Impact factor: 27.401

Review 7.  Replication of Epstein-Barr viral DNA.

Authors:  Wolfgang Hammerschmidt; Bill Sugden
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

Review 8.  Chromatin organization of gammaherpesvirus latent genomes.

Authors:  Italo Tempera; Paul M Lieberman
Journal:  Biochim Biophys Acta       Date:  2009-10-22

9.  Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication.

Authors:  Xi Shen; Huong Do; Yongjiang Li; Woo-Hyun Chung; Maria Tomasz; Johan P de Winter; Bing Xia; Stephen J Elledge; Weidong Wang; Lei Li
Journal:  Mol Cell       Date:  2009-09-11       Impact factor: 17.970

10.  DNA of a circular minichromosome linearized by restriction enzymes or other reagents is resistant to further cleavage: an influence of chromatin topology on the accessibility of DNA.

Authors:  Sławomir Kumala; Yasmina Hadj-Sahraoui; Joanna Rzeszowska-Wolny; Ronald Hancock
Journal:  Nucleic Acids Res       Date:  2012-07-30       Impact factor: 16.971
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.